(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(-0.03%) $78.98
(5.33%) $2.04
(0.13%) $2 313.90
(0.58%) $26.90
(0.80%) $962.55
(-0.08%) $0.932
(-0.36%) $10.99
(-0.12%) $0.798
(-1.36%) $91.99
Live Chart Being Loaded With Signals
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 610 125 |
Vidutinė apimtis | 334 783 |
Rinkos kapitalizacija | 26.23M |
EPS | $0 ( 2024-04-01 ) |
Kita pelno data | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.770 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Sorensen Peter | Buy | 0 | |
2023-12-30 | Manchester Management Co Llc | Buy | 0 | Future Advance Convertible Promissory Note |
2023-12-30 | Manchester Management Co Llc | Buy | 2 500 000 | Common Stock Purchase Warrant |
2023-12-30 | Manchester Management Co Llc | Buy | 2 500 000 | Common Stock Purchase Warrant |
2023-12-30 | Manchester Management Co Llc | Buy | 2 500 000 | Common Stock Purchase Warrant |
INSIDER POWER |
---|
88.34 |
Last 94 transactions |
Buy: 194 230 063 | Sell: 31 191 675 |
SANUWAVE Health, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
SANUWAVE Health, Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $20.40M |
Bruto pelnas: | $13.61M (66.73 %) |
EPS: | $-0.0325 |
FY | 2023 |
Pajamos: | $20.40M |
Bruto pelnas: | $13.61M (66.73 %) |
EPS: | $-0.0325 |
FY | 2022 |
Pajamos: | $16.74M |
Bruto pelnas: | $12.41M (74.13 %) |
EPS: | $-0.0187 |
FY | 2021 |
Pajamos: | $13.01M |
Bruto pelnas: | $8.02M (61.68 %) |
EPS: | $-0.0720 |
Financial Reports:
No articles found.
SANUWAVE Health, Inc.
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.